Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Delon La Puma

Delon La Puma

Institutions of which they are part

Research technician
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Delon La Puma

Delon La Puma

Delon La Puma

Institutions of which they are part

Research technician
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

Els Drs. Montalban, Tintoré i Tur

A questionnaire and self-administered tests detect the progression of multiple sclerosis

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Dr. Xavier Montalban, Dr. Mar Tintoré and Dr. René Carvajal

Age and treatment may predict risk of multiple sclerosis reactivation

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

Laboratori

Viva in Vitro and Vall d’Hebron will study biomarkers in multiple sclerosis

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

See more

Related professionals

Aida Marisch Delgado

Aida Marisch Delgado

Research technician
Rheumatology
Read more
Victor Martin Riera

Victor Martin Riera

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Marta Cros Perez

Marta Cros Perez

Research technician
Ophtalmology
Read more
Lara Pellicer Arroyo

Lara Pellicer Arroyo

Gestió i Administració
Unitat legal
Legal Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.